Dechra Pharmaceuticals PLC FY23 Rev GBP761.5M
By Christian Moess Laursen Dechra Pharmaceuticals said it swung to a pretax loss on higher finance costs, but that revenue grew on a strong performance by...
Source: marketwatch.com
Stay updated with breaking news from Executive Ian Page. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Christian Moess Laursen Dechra Pharmaceuticals said it swung to a pretax loss on higher finance costs, but that revenue grew on a strong performance by...